EODData

FRA, 6NQ: BIOMED-LUBLIN WYT.SUR.

08 Oct 2025
LAST:

0.9900

CHANGE:
 0.02
OPEN:
1.0080
HIGH:
1.0100
ASK:
0.0000
VOLUME:
5K
CHG(%):
1.79
PREV:
1.0080
LOW:
0.9900
BID:
0.0000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
08 Oct 251.00801.01000.99000.99005K
07 Oct 251.00601.00801.00201.00800
06 Oct 250.99801.00600.99501.00605K
02 Oct 251.00401.01601.00401.01600
01 Oct 251.02801.02800.99301.00000
30 Sep 251.04801.04801.03801.03800
29 Sep 251.00601.05001.00601.05000
26 Sep 250.99801.00800.99801.00405K
25 Sep 251.03001.03000.99700.99705K
24 Sep 251.02401.02801.02201.02805K

COMPANY PROFILE

Name:BIOMED-LUBLIN WYT.SUR.
About:Synthaverse S.A., a pharmaceutical company, manufactures and sells medicinal preparations, medical devices, and laboratory reagents in Poland, rest of the European Union, and internationally. It operates through BCG and Traditional segments. The company offers OnkoBCG 50 and 100, which are oncological immunotherapy products used to treat superficial and non-invasive bladder tumors; GAMMA anty-D 50 and GAMMA anty-D 150, which are human anti-rh0(d) immunoglobulin products used in the prevention of maternal-fetal conflict in terms of the D antigen with the Rh system; GAMMA anty HBs 200 medications for use in passive prophylaxis hepatitis B virus; and BCG 10 tuberculosis vaccines. It also provides Distreptaza, a gynecology and proctology reagent used in medical laboratories, in case of poisoning with pesticides and biochemical and chemical-analytical tests; LAKCID, which is a lactobacillus probiotic drug; and pseudocholinoesteraza, which is a laboratory reagent. In addition, the company engages in the contract production of injection drugs, lyophilisates of active substances in sterile sealed vials, active substances and drugs based on surface and submerged biological culture, and suppository forms of drugs. The company was formerly known as BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. and changed its name to Synthaverse S.A. in July 2023. Synthaverse S.A. was founded in 1944 and is headquartered in Lublin, Poland.
Sector:Healthcare
Industry:Biotechnology
Address:ul. Uniwersytecka 10, Lublin, Poland, 20-029
Website:https://synthaverse.com
ISIN:PLBMDLB00018
LEI:259400OWZM67D079S374

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

P/E Ratio:36.93
Price to Book:2.79
Price to Sales:1.11
EBITDA:19.94M
Shares:70.77M
Market Cap:70.06M

TECHNICAL INDICATORS

MA5:1.00
MA10:1.01
MA20:1.03
MA50:1.09
MA100:1.14
MA200:1.08
RSI14:42.56
WPR14:-100.00
MTM14:-0.02
ROC14:-0.02
ATR:0.02
Week High:1.03
Week Low:0.99
Month High:1.10
Month Low:0.98
Year High:1.38
Year Low:0.79
Volatility:3.34